Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Selectis Health (GBCS) Depreciation Expense (2017 - 2025)

Selectis Health's Depreciation Expense history spans 11 years, with the latest figure at $364699.0 for Q3 2025.

  • Quarterly results put Depreciation Expense at $364699.0 for Q3 2025, down 2.52% from a year ago — trailing twelve months through Sep 2025 was $1.5 million (down 10.59% YoY), and the annual figure for FY2023 was $1.7 million, down 7.06%.
  • Depreciation Expense for Q3 2025 was $364699.0 at Selectis Health, up from $362742.0 in the prior quarter.
  • In the past five years, Depreciation Expense ranged from a high of $1.7 million in Q1 2021 to a low of -$447070.0 in Q3 2021.
  • The 5-year median for Depreciation Expense is $430754.0 (2023), against an average of $440593.9.
  • Peak annual rise in Depreciation Expense hit 366.0% in 2021, while the deepest fall reached 215.29% in 2021.
  • Year by year, Depreciation Expense stood at $447070.0 in 2021, then dropped by 0.64% to $444195.0 in 2022, then decreased by 3.03% to $430754.0 in 2023, then dropped by 13.15% to $374118.0 in 2024, then fell by 2.52% to $364699.0 in 2025.
  • According to Business Quant data, Depreciation Expense over the past three periods came in at $364699.0, $362742.0, and $363020.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.